skip to main content


Title: NOAH-( 15 N/ 13 C)-CEST NMR supersequence for dynamics studies of biomolecules
An NMR supersequence is introduced for the rapid acquisition of 15 N-CEST and methyl- 13 C-CEST experiments in the same pulse sequence for applications to proteins. The high sensitivity and accuracy allows the simultaneous quantitative characterization of backbone and side-chain dynamics on the millisecond timescale ideal for routine screening for alternative protein states.  more » « less
Award ID(s):
2103637
NSF-PAR ID:
10414940
Author(s) / Creator(s):
; ;
Date Published:
Journal Name:
Chemical Communications
Volume:
58
Issue:
66
ISSN:
1359-7345
Page Range / eLocation ID:
9258 to 9261
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Abstract

    Three paramagnetic CoIImacrocyclic complexes containing 2‐hydroxypropyl pendant groups, 1,1′,1′′,1′′′‐(1,4,8,11‐tetraazacyclotetradecane‐1,4,8,11‐tetrayl)tetrakis‐ (propan‐2‐ol) ([Co(L1)]2+, 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(propan‐2‐ol) ([Co(L2)]2+), and 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(octadecan‐2‐ol) ([Co(L3)]2+) were synthesized to prepare transition metal liposomal chemical exchange saturation transfer (lipoCEST) agents. In solution, ([Co(L1)]2+) forms two isomers as shown by1H NMR spectroscopy. X‐ray crystallographic studies show one isomer with 1,8‐pendants incis‐configuration and a second isomer with 1,4‐pendants intrans‐configuration. The [Co(L2)]2+complex has 1,8‐pendants in acis‐configuration. Remarkably, the paramagnetic‐induced shift of water1H NMR resonances in the presence of the [Co(L1)]2+complex is as large as that observed for one of the most effective LnIIIwater proton shift agents. Incorporation of [Co(L1)]2+into the liposome aqueous core, followed by dialysis against a solution of 300 mOsm L−1produces a CEST peak at 3.5 ppm. Incorporation of the amphiphilic [Co(L3)]2+complex into the liposome bilayer produces a more highly shifted CEST peak at −13 ppm. Taken together, these data demonstrate the feasibility of preparing CoIIlipoCEST agents.

     
    more » « less
  2. Abstract

    Three paramagnetic CoIImacrocyclic complexes containing 2‐hydroxypropyl pendant groups, 1,1′,1′′,1′′′‐(1,4,8,11‐tetraazacyclotetradecane‐1,4,8,11‐tetrayl)tetrakis‐ (propan‐2‐ol) ([Co(L1)]2+, 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(propan‐2‐ol) ([Co(L2)]2+), and 1,1′‐(4,11‐dibenzyl‐1,4,8,11‐tetraazacyclotetradecane‐1,8‐diyl)bis(octadecan‐2‐ol) ([Co(L3)]2+) were synthesized to prepare transition metal liposomal chemical exchange saturation transfer (lipoCEST) agents. In solution, ([Co(L1)]2+) forms two isomers as shown by1H NMR spectroscopy. X‐ray crystallographic studies show one isomer with 1,8‐pendants incis‐configuration and a second isomer with 1,4‐pendants intrans‐configuration. The [Co(L2)]2+complex has 1,8‐pendants in acis‐configuration. Remarkably, the paramagnetic‐induced shift of water1H NMR resonances in the presence of the [Co(L1)]2+complex is as large as that observed for one of the most effective LnIIIwater proton shift agents. Incorporation of [Co(L1)]2+into the liposome aqueous core, followed by dialysis against a solution of 300 mOsm L−1produces a CEST peak at 3.5 ppm. Incorporation of the amphiphilic [Co(L3)]2+complex into the liposome bilayer produces a more highly shifted CEST peak at −13 ppm. Taken together, these data demonstrate the feasibility of preparing CoIIlipoCEST agents.

     
    more » « less
  3. At the beginning of the millennium, the first chemical exchange saturation transfer (CEST) contrast agents were bio‐organic molecules. However, later, metal‐based CEST agents (paraCEST agents) took center stage. This did not last too long as paraCEST agents showed limited translational potential. By contrast, the CEST field gradually became dominated by metal‐free CEST agents. One branch of research stemming from the original work by van Zijl and colleagues is the development of CEST agents based on polypeptides. Indeed, in the last 2 decades, tremendous progress has been achieved in this field. This includes the design of novel peptides as biosensors, genetically encoded recombinant as well as synthetic reporters. This was a result of extensive characterization and elucidation of the theoretical requirements for rational designing and engineering of such agents. Here, we provide an extensive overview of the evolution of more precise protein‐based CEST agents, review the rationalization of enzyme‐substrate pairs as CEST contrast enhancers, discuss the theoretical considerations to improve peptide selectivity, specificity and enhance CEST contrast. Moreover, we discuss the strong influence of synthetic biology on the development of the next generation of protein‐based CEST contrast agents.

     
    more » « less
  4. Abstract

    Chemical exchange saturation transfer (CEST) MRI has been identified as a novel alternative to classical diagnostic imaging. Over the last several decades, many studies have been conducted to determine possible CEST agents, such as endogenously expressed compounds or proteins, that can be utilized to produce contrast with minimally invasive procedures and reduced or non‐existent levels of toxicity. In recent years there has been an increased interest in the generation of genetically engineered CEST contrast agents, typically based on existing proteins with CEST contrast or modified to produce CEST contrast. We have developed an in silico method for the evolution of peptide sequences to optimize CEST contrast and showed that these peptides could be combined to create de novo biosensors for CEST MRI. A single protein, superCESTide, was designed to be 198 amino acids. SuperCESTide was expressed inE. coliand purified with size exclusion chromatography. The magnetic transfer ratio asymmetry generated by superCESTide was comparable to levels seen in previous CEST reporters, such as protamine sulfate (salmon protamine) and human protamine. These data show that novel peptides with sequences optimized in silico for CEST contrast that utilize a more comprehensive range of amino acids can still produce contrast when assembled into protein units expressed in complex living environments.

     
    more » « less
  5. Abstract Purpose

    CEST MRI has been used to probe changes in cardiac metabolism via assessment of CEST contrast from Cr. However, B1variation across the myocardium leads to spatially variable Cr CEST contrast in healthy myocardium.

    Methods

    We developed a spatial–spectral (SPSP) saturation pulsed CEST protocol to compensate for B1variation. Flip angle maps were used to individually tailor SPSP pulses comprised of a train of one‐dimensional spatially selective subpulses selective along the principal B1gradient dimension. Complete Z‐spectra in the hearts of (n = 10) healthy individuals were acquired using conventional Gaussian saturation and SPSP schemes and supported by phantom studies.

    Results

    In simulations, the use of SPSP pulses reduced the average SD of the effective saturation B1values within the myocardium (n = 10) from 0.12 ± 0.02 μT to 0.05 ± 0.01 μT (p < 0.01) and reduced the average SD of Cr CEST contrast in vivo from 10.0 ± 4.3% to 6.1 ± 3.5% (p < 0.05). Results from the hearts of human subjects showed a significant reduction of CEST contrast distribution at 2 ppm, as well as amplitude, when using SPSP saturation. Corresponding phantom experiments revealed PCr‐specific contrast generation at body temperature when SPSP saturation was used but combined PCr and Cr contrast generation when Gaussian saturation was used.

    Conclusion

    The use of SPSP saturation pulsed CEST resulted in PCr‐specific contrast generation and enabled ratiometric mapping of PCr to total Cr CEST contrast in the human heart at 3T.

     
    more » « less